This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Innovation of Iglarlexi in Intensification

Prof. Abdulrahman Al Sheikh, consultant endocrinology and diabetes, presenting the first head-to-head comparison of iGlarLixi and premix insulin.

New to Campus Sanofi? Register to access all our Content

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.